Echo Therapeutics (ECTE) Posts Wider than Expected Q2 Loss of 8c/Share
Tweet Send to a FriendGet Alerts ECTE Hot Sheet
Price: $0.48 --0%
Revenue Growth %: -100.0%
Financial Fact:
Total revenues: 22.56K
Today's EPS Names:
SNPS, SPTN, GAME, More
Revenue Growth %: -100.0%
Financial Fact:
Total revenues: 22.56K
Today's EPS Names:
SNPS, SPTN, GAME, More
Trade ECTE Now!
Echo Therapeutics (NASDAQ: ECTE) reported Q2 EPS of ($0.08), $0.01 worse than the analyst estimate of ($0.07). Revenue for the quarter came in at $30.9 thousand versus the consensus estimate of $190 thousand.
For earnings history and earnings-related data on Echo Therapeutics (ECTE) click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
For earnings history and earnings-related data on Echo Therapeutics (ECTE) click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- NetApp (NTAP) Tops Q4 EPS by 1c; Boosts Buyback, Plans Job Cuts, Initiates Dividend
- UPDATE: Applied Materials, Inc. (AMAT) Tops Q2 EPS by 3c, Offers Guidance
- hhgregg, Inc. (HGG) Tops Q4 EPS by 1c; Guides FY14 EPS
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
